Rickettsia prowazekii, the etiologic agent of epidemic typhus, infects vascular endothelium, leading to vasculitis and tissue infiltration of leukocytes. Murine and human endothelial cells (ECs) were infected with R. prowazekii, including the virulent Breinl strain and the attenuated Madrid E strain. The transendothelial migration (TM) of murine and human peripheral blood mononuclear cells (PBMCs) across ECs infected with Breinl organisms was significantly increased compared with that for uninfected ECs or for ECs infected with attenuated organisms, demonstrating that increased TM was related to R. prowazekii virulence. Increased TM was associated with a specific inflammatory pattern. Indeed, only Breinl organisms induced the expression of transcripts for inflammatory cytokines and chemokines by ECs. Murine PBMCs that had transmigrated across ECs infected with Breinl organisms overexpressed inflammatory cytokines and chemokines as well as tissue factor, whereas interleukin-10 expression was down-regulated. The impact of R. prowazekii infection on the TM of PBMCs may play a prominent role in the development of lesions in epidemic typhus.
Rickettsiae are obligate intracellular bacteria that multiply within vascular endothelial cells (ECs) and cause spotted fever and typhus-related diseases. Among the latter, epidemic typhus (ET), one of the most important infectious diseases of the last 500 years, is due to Rickettsia prowazekii that is transmitted to humans by body lice [1, 2] . Clinical manifestations of ET include generalized vasculitis and multifocal inflammatory lesions made of mononuclear cells [3] . Lungs and brain are mainly affected: interstitial pneumonia is characterized by infiltration of the alveolar walls by mononuclear cells and may lead to acute respiratory distress syndrome, and neurological deficits may lead to seizures and coma [2, 3] . R. prowazekii is considered as a potential category B biological weapon. Its virulence varies among strains: the Breinl strain [4] and the Batna Rp22 strain [5] , recently isolated in our laboratory, are highly virulent, whereas the Madrid E strain is not pathogenic for humans and has a reduced capacity to kill experimental animals [6] .
Many of the pathogenic steps in rickettsial pathogenesis are not established. Human ECs respond to infection with spotted fever rickettsiae by increasing expression of adhesion molecules that favor leukocyte adherence to ECs [7, 8] . Infected ECs overproduce inflammatory cytokines (including interleukin [IL]-1␣, IL-6, and IL-8 [9, 10] ) and chemokines (including CCL2 [11] , CXCL9, and CXCL10 [12] ) through activation of the transcription factor NF-B [13, 14] . Infected ECs also release vasoactive mediators [15] and tissue factor (TF) [16] , leading to a switch from a nonthrombogenic to a procoagulant EC phenotype [14] and to changes in vessel wall permeability, causing fluid imbalance [17] . Only a few reports describing the effect of R. prowazekii infection on EC response are available. Indeed, infected ECs overproduce leukotrienes, prostaglandins, and platelet-activating factor [18, 19] . Because ET remains a major disease threat, we have recently described a murine model of ET that reproduces some features of the human disease. Our results suggest that BALB/c mice provide a convenient model for studying the pathogenic mechanisms of ET and its control by the immune system [20] . We demonstrate here that the transendothelial migration (TM) of peripheral blood mononuclear cells (PBMCs) isolated from humans or mice was significantly increased when ECs were infected with virulent organisms, not with attenuated organisms. Infected ECs overexpressed inflammatory cytokines and chemokines, and transmigrated PBMCs acquired an inflammatory transcriptional profile. R. prowazekii infection of ECs may provide an exaggerated inflammatory signal for PBMC extravasation in surrounding tissues, leading to the development of lesions in ET.
MATERIALS AND METHODS
Bacterial preparation. R. prowazekii strains Breinl (ATCC VR-142), Batna Rp22, and Madrid E were propagated as described elsewhere [20] . L929 cells were infected with organisms in Dulbecco's modified Eagle medium (DMEM) supplemented with 2% fetal bovine serum (FBS) and 2 mmol/L L-glutamine (Invitrogen) for 7 days at 35°C. Infected cells were harvested and disrupted by passage through a needle, and cell debris were removed by low-speed centrifugation at 1000 g. The supernatants containing bacteria were centrifuged at 7500 g for 10 min. Bacteria were suspended in PBS and layered on 25%-45% linear Renografin gradient, and the gradients were centrifuged. Collected bacteria were washed and then stored at Ϫ80°C. The bacterial concentration was determined by plate titration assay, as described elsewhere [21] . Briefly, confluent L929 cells (in 96-well plates) were inoculated with 5-fold serial dilutions of an aliquoted bacterial sample of unknown concentration or a sample containing a known bacterial concentration. Each dilution was tested in triplicate. Plates were then incubated for 12 days at 37°C, and bacteria were revealed by Gimenez staining and/or immunofluorescence. The last dilutions of bacterial samples of unknown and known concentrations that gave 50% positive cultures were determined. The concentration of the aliquoted bacterial sample was calculated relative to the sample of known concentration. The identity of R. prowazekii organisms was checked by sequencing polymerase chain reaction (PCR) products by use of the gltA primers, as described elsewhere [22] . Heat-inactivated organisms were obtained by 60°C treatment for 30 min.
EC culture and PBMC preparation. The murine lung microvascular EC line L2 and the human microvascular EC line HMEC-1 were provided by G. E. Grau (Sidney, Australia) and were used with his permission. ECs were cultured in EC growth medium (DMEM-F12) supplemented with 10% FBS and 1% EC growth factor (Cambrex BioSciences), as described elsewhere [23] . After trypsinization, ECs were seeded in gelatin-coated 96-well plates or inserts (8-m pore size; Costar) in 24-well plates (5 ϫ 10 4 cells/well) and cultured until tight confluence. Only confluent cultures with a resistivity of 250 Ϯ 50 ⍀/cm 2 were used. PBMCs from BALB/c mice were isolated from EDTAanticoagulated blood by use of Optiprep (AbCys) flotisant gradient. After a 15-min centrifugation at 1000 g, PBMCs were washed twice and suspended in 1 mL of DMEM-F12 containing 10% FBS. Human PBMCs were isolated from EDTAanticoagulated blood by Ficoll gradient (MSL; Eurobio), as described elsewhere [23] . Infection procedure. Confluent ECs were infected with R. prowazekii (bacterium to cell ratio of 50:1) at 37°C. After different periods of time, unbound organisms were removed by extensive washing. In some experiments, supernatants of ECs cultured for 6 h were stored at Ϫ20°C. Bacterial uptake was determined by quantitative real-time PCR, as described elsewhere [24] . In brief, ECs were suspended by pipeting in 0.1% Triton X-100. DNA was extracted in a 100-L volume, by use of the QIAamp Tissue Kit (Qiagen) in accordance with the manufacturer's instructions. The number of bacterial DNA copies was calculated using the LightCycler system (Roche Diagnostics) with 5-L DNA samples. The selected primers and probe of the gltA gene specific for R. prowazekii were RproF (5'-TCGGTAAAGATGTAATCGATATAAG-3'), RproR (5'-CAT-ATCCTCGATACCATAATATGC-3'), and Rp probe (5'-FAM-ACTTTACTTATGATCCGGGTTTTATGTA-MRA-3'), leading to a PCR product size of 154 bp. Negative controls consisted of DNA extracted from uninfected ECs. Each PCR run included a standard curve of 10-fold serial dilutions of a known concentration of R. prowazekii DNA, determined using a standardized plasmid previously developed in our laboratory [25] and calculated by use of the LightCycler 5.32 software (LC-Run Version 5.32; Roche). Bacterial uptake was also determined by immunofluorescence, as described elsewhere [26] . ECs were fixed with 3% paraformaldehyde and permeabilized with 0.1 % Triton X-100. After washing, ECs were incubated with mouse antibodies directed against R. prowazekii or with control serum at 1:500 dilution for 30 min. After washing, a 1:500 dilution of Alexa 488 -conjugated F(ab') 2 anti-mouse IgG (Molecular Probes) was added to ECs for 30 min. The number of ingested bacteria was determined by fluorescence microscopy with a Zeiss microscope. The infection index was defined as follows: (number of bacteria per positive EC) ϫ (percentage of positive cells) ϫ 100.
TM assay. A TM assay was performed as described elsewhere [23] . In brief, ECs deposited on inserts were infected with R. prowazekii (bacterium to cell ratio of 50:1) for 6 h at 37°C. Nonadherent bacteria were removed by washing. In some experiments, PBMCs were stimulated with 1 g/mL phytohemagglutinin (PHA; Life Technologies), a powerful inducer of TM. Unstimulated or PHA-stimulated PBMCs (4 ϫ 10 5 PBMCs/well) were added to ECs for different periods. PBMCs that had migrated were collected, centrifuged, and enumerated by trypanblue exclusion. Results are expressed as the percentage of PBMCs having migrated across ECs.
Quantitative real-time reverse-transcription PCR (RT-PCR). RNA from ECs or transmigrated PBMCs was extracted using Qiagen kits, as described by the manufacturer. The integ-rity and amount of RNA were assessed using the 2100 Bioanalyzer and the RNA 6000 Nano LabChip Kit (Agilent Technologies) after a DNase digestion step. The cDNA synthesis was done with 10 ng of total RNA, oligo(dT) primer, and M-MLV reverse transcriptase (Invitrogen), in accordance with the manufacturer's protocol. PCR was performed using the LightCycler. Briefly, amplification was conducted in a 20-L volume with SYBR Green PCR Master Mix (Roche Diagnostics), 2 L of template cDNA, 1 L (10 pmol) each of forward and reverse gene-specific primers, 2 L of 3 mmol/L MgCl 2 , and 12 L H 2 O. The primer sequences are listed in table 1. Reverse transcriptase was omitted in negative controls. The fold change (FC) in target gene cDNA relative to the ␤-actin endogenous control was determined as follows: FC ϭ 2 Ϫ⌬⌬Ct , where ⌬⌬Ct ϭ (Ct target Ϫ Ct actin ) infected Ϫ (Ct target Ϫ Ct actin ) uninfected . Ct values were defined as the number of cycles for which the fluorescence signals were detected [27] . The FC of PBMCs that had transmigrated across infected ECs was calculated relative to PBMCs that had transmigrated across uninfected ECs. We considered as modulated only gene expression with a FC Ͼ 1.5.
Statistical analysis. Results are expressed as mean Ϯ SD values and were compared using the Mann-Whitney U test. Differences were considered significant when P Ͻ .05. Statistical analyses were performed using Prism software (version 4.0; GraphPad Software).
RESULTS

Effect of EC infection on the TM of PBMCs.
In a first series of experiments, the infection of confluent murine ECs with R. prowazekii organisms was studied. When ECs were incubated with virulent Breinl organisms (bacterium to cell ratio of 50:1), bacterial DNA was detected at 2 h. The number of bacterial DNA copies increased at 4 and 6 h ( figure 1A) . When ECs were incubated with attenuated Madrid E or virulent Batna Rp22 organisms, the number of bacterial DNA copies was similar to that found with Breinl organisms, whatever the time of incubation of ECs with bacteria ( figure 1A) . The results obtained by indirect immunofluorescence were superimposable to those obtained by quantitative PCR. Indeed, only ϳ60% of ECs were infected with 1 bacterium/cell at 2 h, 70%-80% of ECs were infected with a mean number of 3 bacteria/cell at 4 h, and 100% of ECs were infected with a mean number of 5 bacteria/cell at 6 h, indepen- dently of the virulence of bacterial strains ( figure 1B) . In subsequent experiments, ECs were infected with 50 bacteria/cell for 6 h. We then studied the effect of the infection of murine ECs with R. prowazekii on the TM of murine PBMCs. Less than 10% of PBMCs migrated across uninfected EC after 2 h, and the percentage of transmigrated PBMCs steadily increased to reach ϳ15% after 24 h. When ECs were infected with Breinl organisms, the TM was significantly increased compared with that with uninfected EC, whatever the duration of the TM assay. After 24 h, 29% Ϯ 4% of PBMCs migrated across infected ECs, whereas only 16% Ϯ 2% of PBMCs migrated across uninfected ECs (P Ͻ .005); this percentage was close to that of PHAstimulated PBMCs ( figure 1C) . In contrast, EC infection with attenuated Madrid E organisms did not affect the TM of PBMCs compared with that with uninfected ECs. When ECs were infected with Rp22 organisms, ϳ30% of PBMCs migrated across infected ECs ( figure 1D ), demonstrating that increased TM was related to R. prowazekii virulence. We also wondered whether the infection of human ECs with R. prowazekii affected the TM of human PBMCs. First, the infection of confluent human ECs with R. prowazekii organisms was studied by quantitative PCR. No difference was found between Breinl and Madrid E organisms. Indeed, after a 6-h incubation, the number of bacterial copies was 3.2 Ϯ 0.5 ϫ 10 5 and 3.5 Ϯ 0.3 ϫ 10 5 , respectively. Second, the infection of ECs with Breinl organisms for 6 h increased significantly (P Ͻ .05) the TM of human PBMCs (45% Ϯ 4% vs. 22% Ϯ 3% for uninfected ECs after a 24-h TM assay), whereas infection with Madrid E organisms did not have an effect on the TM of PBMCs (25% Ϯ 2%). These results demonstrate that increased TM of PBMCs across infected ECs was related to bacterial virulence, not to the types of eukaryotic cells.
Inflammatory pattern of infected ECs. We wondered whether R. prowazekii stimulates different inflammatory patterns in infected ECs according to bacterial virulence. Murine ECs were infected with R. prowazekii organisms for 6 h and then washed, and the expression of inflammatory cytokines and chemokines was studied by RT-PCR (figure 2A). Compared with uninfected ECs, ECs infected with Breinl organisms expressed high levels of mRNA encoding tumor necrosis factor (TNF)-␣, IL-1␣, IL-6, CXCL-10, and, to a lesser extent, CCL-2 and CCL-5. In contrast, the attenuated strain Madrid E poorly affected the production of mRNA encoding TNF-␣, IL-1␣, IL-6, and CCL-5. It was without effect on the level of CCL-2 mRNA but stimulated the production of CXCL-10 mRNA. Interestingly, infection of ECs with Breinl organisms, but not with Madrid E organisms, increased the expression of mRNA encoding TF. We also studied the transcriptional profile of human ECs infected with R. prowazekii for 6 h. Human ECs infected with Breinl organisms expressed high levels of mRNA encoding inflammatory cytokines and chemokines (expression levels comprised between 4 and 8). Again, in response to the infection with Madrid E organ- isms, human ECs did not express mRNA encoding inflammatory cytokines or expressed low levels of mRNA encoding CCL-2 and CCL-5 (data not shown). Note that mRNA encoding CXCL-10 was increased, as found for murine ECs. These results show that the inflammatory profile of infected ECs was associated with bacterial virulence.
Transcriptional profile of transmigrated PBMCs. We wondered whether the different activation states of ECs induced by Breinl and Madrid E organisms affect the expression by PBMCs of transcripts encoding cytokines and chemokines. First, the inflammatory profile of murine PBMCs, which had migrated across uninfected or infected ECs, was analyzed by RT-PCR. After 6 h of TM, mRNA for TNF-␣, IL-12p35, CXCL-10, CCL-2, CCL-5 and TF was already increased in PBMCs that had migrated across ECs infected with Breinl organisms, compared with those that had migrated across uninfected ECs (data not shown). After 24 h of TM, they were significantly (P Ͻ .05) increased ( figure 2B ). In addition, IL-10 mRNA levels were decreased, reinforcing the proinflammatory profile of PBMCs that had transmigrated. In contrast to ECs infected with Breinl organisms, ECs infected with Madrid E organisms down-regulated the expression of mRNA of TNF-␣ and IL-12p35 by PBMCs and did not affect the expression of mRNA encoding IL-10, CXCL-10, CCL-2, CCL-5, and TF ( figure 2B ). Second, we wondered whether the increased expression of inflammatory genes in transmigrated PBMCs is the result of soluble mediators produced by infected ECs. PBMCs were incubated with the supernatants of uninfected or infected ECs for 24 h, and their inflammatory profile was studied. Supernatants from ECs infected with Breinl organisms induced an inflammatory pattern in PBMCs similar to that of PBMCs that had transmigrated across ECs infected with Breinl organisms ( figure 2C ). In contrast, supernatants from ECs infected with Madrid E organisms were unable to modulate mRNA encoding inflammatory cytokines, chemokines, or TF. These results clearly demonstrated that the crosstalk of ECs with PBMCs resulted from the release of cytokines and chemokines by ECs infected with virulent R. prowazekii.
DISCUSSION
We demonstrate here that the infection of murine ECs with virulent R. prowazekii, but not attenuated organisms, increased the TM of murine PBMCs. The infection of human ECs also increased the TM of human PBMCs, suggesting that a general mechanism was responsible for increased TM. To our knowledge, this is the first demonstration that rickettsiae affect leukocyte TM. It has only been shown that ECs infected with R. conorii [10] or R. rickettsii [11] produce cytokines (including IL-6 and IL-1␣) and chemokines (including IL-8 and CCL-2) that may play a role in leukocyte TM. Other pathogens are able to modulate the TM of PBMCs. Indeed, human ECs infected with different Chlamydia pneumoniae isolates stimulate the TM of neutrophils and monocytes [28] . Cytomegalovirus infection of ECs increases the TM of neutrophils [29] . T cell recruitment in response to Helicobater pylori infection of ECs has also been reported [30] .
TM is mediated by multiple receptor-ligand pairs, which act sequentially and in an overlapping manner to effect initial attachement, rolling, firm adhesion, and, finally, transmigration of leukocytes. Because this complex phenomenon is driven by inflammatory cytokines and chemokines [31] , we studied the transcriptional profile of ECs infected with R. prowazekii. When ECs were infected with virulent organisms, increased expression of genes encoding inflammatory cytokines (such as TNF-␣, IL-1␣, IL-6) and chemokines (including CXCL-10, CCL-2, and CCL-5) was observed. Increased IL-1 may amplify the production of other cytokines and chemokines in an autocrine or paracrine manner [32] . TNF-␣, a potent inflammatory mediator, is involved in the adhesion and TM of PBMCs through the activation of the transcriptional factor NF-B [33, 34] . CCL-2, CCL-5, and CXCL-10 are 3 major chemokines known to target specific leukocyte subsets [35] . In contrast to virulent organisms, attenuated organisms were unable to stimulate an inflammatory transcriptional profile in ECs with the notable exception of CXCL-10, suggesting that up-regulated expression of mRNA encoding inflammatory mediators did not result from the infection of ECs per se.
Because ECs infected with virulent R. prowazekii produced inflammatory cytokines and chemokines, we reasoned that these molecules may activate transmigrated PBMCs. We clearly show that PBMCs that migrated across infected ECs acquired an inflammatory transcriptional profile. In addition, mRNA encoding TF, a potent procoagulant molecule [36] , was increased in ECs infected with virulent R. prowazekii and in PBMCs that had migrated across infected ECs. It is well known that the expression of TF is induced by inflammatory stimuli, including lipopolysaccharide and TNF-␣ [37] . Finally, the expression of IL-10, a potent anti-inflammatory cytokine [38] , was decreased, reinforcing the inflammatory profile of transmigrated PBMCs. The inflammatory profile acquired by transmigrated PBMCs is due to the release of inflammatory mediators by ECs infected with virulent R. prowazekii. This effect is related to bacterial virulence, given that ECs infected with attenuated organisms were unable to stimulate PBMCs. It is likely that increased migration of PBMCs across infected ECs was due to an amplification loop, leading to an exaggerated inflammatory response.
ET is characterized by an intense inflammatory response and vascular changes that likely lead to pulmonary and cerebral lesions [3] , but the mechanisms governing the formation of lesions remain to be elucidated. Our in vitro findings indicate that infection of ECs with R. prowazekii increases the migration of leukocytes across endothelium through an exacerbated inflammatory response. We have recently shown that the lesions induced by R. prowazekii in the livers, lungs, and brains of mice are associated with a local inflammatory response [20] . We can therefore suppose that the exacerbated inflammatory response induced by R. prowazekii promotes leukocyte extravasation in the surrounding tissues and the formation of occlusive thrombosis through tissue recruitment and the local accumulation of leukocytes.
